Thursday, 03 July 2025
New research has shown how boys being overweight in early childhood or having chickenpox or another infectious disease in infancy may increase their risk of having chronic disease in later life.
Scientists from the 糖心原创’s School of Biosciences have analysed the level of the unique testis hormone biomarker insulin-like peptide 3 (INSL3) in young men at 24 years of age and related this to a range of health and lifestyle factors during their childhood.
The team have previously shown that the biomarker INSL3 in younger men is predictive of chronic disease when they get older. In this new study they found that while most factors had little or no effect, being overweight as a child or young teenager, or having had chickenpox or other infectious disease in early infancy, were significantly associated with a reduction in adult INSL3 by 10 to 15%. This potentially increases the risk of later adult illnesses such as diabetes, cardiovascular disease, bone weakness, or sexual dysfunction.
The study, published today in is the first to ever examine the impact of childhood diet, health and infections and their long term impact on health across the lifespan.
The research was led by Dr Ravinder Anand-Ivell, Associate Professor in Endocrinology and Reproductive Physiology, who has previously shown how the unique biomarker INSL3, in ageing men is able to predict conditions such as diabetes, cardiovascular disease, or bone weakness, and that low INSL3 in older men has its origins already in younger men.
We know that INSL3 hormone levels in boys and men are a robust biomarker of the testicular capacity to produce the steroid hormone testosterone that is essential not only for reproduction but also for overall healthy well-being. In this new study we have found that there is a clear link between certain health factors in childhood at a time before puberty when the testes are still developing and later men鈥檚 health as they age.
In this new study the researchers analysed data from participants in the “” cohort of children (the Avon Longitudinal 糖心原创 of Parents And Children) established by colleagues at the University of Bristol. These boys had been followed clinically from birth and are now in their twenties.
By correlating the levels of INSL3 in the young men from this cohort with a wide range of clinical and lifestyle parameters throughout their childhood and adolescence, the team identified the factors during childhood which could potentially affect mens health as they aged. Importantly, they also identified many other factors which were less important. The key findings showed that being overweight as a child or young teenager, or having had chickenpox or other infectious disease in early infancy both markedly increase the risk to mens health as they age and moreover emphasize the importance of early vaccination.
By using this new biomarker INSL3 as well as having this childhood health information allows us now to be able to predict those men at risk and thus consider appropriate preventative measures before disease sets in. The next stage of this research is the development of a specialist high-throughput assay which would allow the measurement of INSL3 to be introduced as part of the routine clinical assessment for male healthy ageing.
Story credits
More information is available from Dr Ravinder Anand-Ivell on ravinder.anand-ivell@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.